PMS – New Insights and Treatment Options
Many women experience severe PMS (premenstrual syndrome) and PMDD (premenstrual dysphoric disorder) that is debilitating and disruptive to daily life. They are left feeling devastated and need advanced measures to alleviated suffering. When dealing with PMS and PMDD, hormonal imbalances are often the emphasis but more research is supporting the correlation between PMS and PMDD and neurotransmitters.
In the June 2012 edition of Menopause International, UCLA researchers reported their findings on the pathophysiology of PMS and PMDD as it relates to neurotransmitters. Research is showing that both GABA and serotonin are altered or lowered in the luteal phase of a woman’s menstrual cycle contributing to PMS and PMDD.
When treating a woman with PMS and PMDD it is important to address nutritional support, lifestyle changes, exercise routines, as well as neurotransmitter and hormonal imbalances. Emerging research supports the importance of comprehensive neuroendocrine evaluation that includes an emphasis on GABA and serotonin levels.
Our clinic uses an individual approach to help each woman achieve balance and a sense of peace and wellbeing.
